BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11505457)

  • 1. Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia.
    Marais DJ; Best JM; Rose RC; Keating P; Soeters R; Denny L; Dehaeck CM; Nevin J; Kay P; Passmore JA; Williamson AL
    J Med Virol; 2001 Sep; 65(1):149-54. PubMed ID: 11505457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D; Rose RC; Williamson AL
    J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions.
    Sasagawa T; Yamazaki H; Dong YZ; Satake S; Tateno M; Inoue M
    Int J Cancer; 1998 Feb; 75(4):529-35. PubMed ID: 9466652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
    Marais DJ; Rose RC; Lane C; Kay P; Nevin J; Denny L; Soeters R; Dehaeck CM; Williamson AL
    J Med Virol; 2000 Apr; 60(4):403-10. PubMed ID: 10686023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA.
    Wang Z; Hansson BG; Forslund O; Dillner L; Sapp M; Schiller JT; Bjerre B; Dillner J
    J Clin Microbiol; 1996 Dec; 34(12):3056-62. PubMed ID: 8940448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
    Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
    Bontkes HJ; de Gruijl TD; Walboomers JM; Schiller JT; Dillner J; Helmerhorst TJ; Verheijen RH; Scheper RJ; Meijer CJ
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():409-417. PubMed ID: 10073701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
    Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
    Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids.
    Sasagawa T; Rose RC; Azar KK; Sakai A; Inoue M
    Int J Cancer; 2003 Apr; 104(3):328-35. PubMed ID: 12569556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles.
    Tachezy R; Hamsíková E; Hájek T; Mikysková I; Smahel M; Van Ranst M; Kanka J; Havránková A; Rob L; Guttner V; Slavík V; Anton M; Kratochvíl B; Kotrsová L; Vonka V
    J Med Virol; 1999 Aug; 58(4):378-86. PubMed ID: 10421405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions.
    Marais DJ; Vardas E; Ramjee G; Allan B; Kay P; Rose RC; Williamson AL
    J Infect Dis; 2000 Oct; 182(4):1239-42. PubMed ID: 10979925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.
    Einstein MH; Studentsov YY; Ho GY; Fazzari M; Marks M; Kadish AS; Goldberg GL; Runowicz CD; Burk RD
    Int J Cancer; 2007 Jan; 120(1):55-9. PubMed ID: 17036320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) cervical infections in women with normal and abnormal cytology.
    Szkaradkiewicz A; Wal M; Kuch A; Pieta P
    Pol J Microbiol; 2004; 53(2):95-9. PubMed ID: 15478354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies.
    Baay MF; Duk JM; Groenier KH; Burger MP; de Bruijn HW; Hollema H; Stolz E; Herbrink P
    Cancer Immunol Immunother; 1997 Jun; 44(4):211-5. PubMed ID: 9222279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human papillomaviruses in the healthy oral mucosa of women with high-grade squamous intra-epithelial lesion and of their partners as compared to healthy controls.
    Tatár TZ; Kis A; Szabó É; Czompa L; Boda R; Tar I; Szarka K
    J Oral Pathol Med; 2015 Oct; 44(9):722-7. PubMed ID: 25495524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions.
    Wideroff L; Schiffman M; Haderer P; Armstrong A; Greer CE; Manos MM; Burk RD; Scott DR; Sherman ME; Schiller JT; Hoover RN; Tarone RE; Kirnbauer R
    J Infect Dis; 1999 Nov; 180(5):1424-8. PubMed ID: 10515799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.
    Elfgren K; Bistoletti P; Dillner L; Walboomers JM; Meijer CJ; Dillner J
    Am J Obstet Gynecol; 1996 Mar; 174(3):937-42. PubMed ID: 8633673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary study on the relationship between loads of human papillomavirus in cervical carcinoma and cervical intraepithelial neoplasia].
    Li SM; Zhang WH; Wu LY; Zhao FH; Huang MN; Li N; Chen F
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):400-2. PubMed ID: 15312325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
    Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Walboomers JM; Meijer CJ; Shah KV; Clayman B; Viscidi RP
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):935-40. PubMed ID: 10548324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.